Key result
Takotsubo cardiomyopathy after aSAH is linked to a ~64% higher risk of poor outcomes and mortality.
Why the study?
Takotsubo cardiomyopathy in patients with aneurysmal subarachnoid hemorrhage is associated with high morbidity and mortality, but risk factors and outcomes with intra-aortic balloon pump use are not well defined.
What are the predictors of Takotsubo cardiomyopathy in patients with aneurysmal subarachnoid hemorrhage, and how does it impact clinical outcomes?
Cohort (n=1,096)
No
What are the predictors of Takotsubo cardiomyopathy in patients with aneurysmal subarachnoid hemorrhage, and how does it impact clinical outcomes?
Answers are grounded in this paper and cite their sources.
Takotsubo cardiomyopathy after aneurysmal subarachnoid hemorrhage is strongly predicted by female sex, poor clinical grade, large aneurysms, and clinical vasospasm, and is associated with significantly worse neurological outcomes and higher mortality despite IABP support.
OBJECTIVE: Takotsubo cardiomyopathy (TC) in patients with aneurysmal subarachnoid hemorrhage (aSAH) is associated with high morbidity and mortality. Previous studies have shown that female patients presenting with a poor clinical grade are at the greatest risk for developing TC. Intra-aortic balloon pumps (IABPs) are known to support cardiac function in severe cases of TC, and they may aid in the treatment of vasospasm in these patients. In this study, the authors investigated risk factors for developing TC in the setting of aSAH and outcomes among patients requiring IABPs. METHODS: The authors retrospectively reviewed the records of 1096 patients who had presented to their institution with aSAH. Four hundred five of these patients were originally enrolled in the Barrow Ruptured Aneurysm Trial, and an additional 691 patients from a subsequent prospectively maintained aSAH database were analyzed. Medical records were reviewed for the presence of TC according to the modified Mayo Clinic criteria. Outcomes were determined at the last follow-up, with a poor outcome defined as a modified Rankin Scale (mRS) score > 2. RESULTS: TC was identified in 26 patients with aSAH. Stepwise multivariate logistic regression analysis identified female sex (OR 8.2, p = 0.005), Hunt and Hess grade > III (OR 7.6, p < 0.001), aneurysm size > 7 mm (OR 3, p = 0.011), and clinical vasospasm (OR 2.9, p = 0.037) as risk factors for developing TC in the setting of aSAH. TC patients, even with IABP placement, had higher rates of poor outcomes (77% vs 47% with an mRS score > 2, p = 0.004) and mortality at the last follow-up (27% vs 11%, p = 0.018) than the non-TC patients. However, aggressive intra-arterial endovascular treatment for vasospasm was associated with good outcomes in the TC patients versus nonaggressive treatment (100% with mRS ≤ 2 at last follow-up vs 53% with mRS > 2, p = 0.040). CONCLUSIONS: TC after aSAH tends to occur in female patients with large aneurysms, poor clinical grades, and clinical vasospasm. These patients have significantly higher rates of poor neurological outcomes, even with the placement of an IABP. However, aggressive intra-arterial endovascular therapy in select patients with vasospasm may improve outcome.
No takes yet. Share an insight, caveat, or question.
Catapano et al. (2020) conducted a cohort in Aneurysmal subarachnoid hemorrhage (n=1,096). Takotsubo cardiomyopathy vs. Non-Takotsubo cardiomyopathy patients was evaluated on Poor outcome (modified Rankin Scale score > 2) (p=0.004). Takotsubo cardiomyopathy after aneurysmal subarachnoid hemorrhage was associated with higher rates of poor outcomes (77% vs 47%, p=0.004) and mortality (27% vs 11%, p=0.018).
Synapse has enriched 10 related papers. Consider them for comparative context: